NORTH CHICAGO, Ill., March 4, 2020 /PRNewswire/ -- AbbVie issued the following form today.IRISH TAKEOVER PANEL

HONG KONG and SHANGHAI, March 4, 2020 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereafter "Ping An" or the "Group", HKEx:2318; SSE:601318) has published its 2019 Sustainability Report, highlighting the Group's achievements and milestones in improving environmental, social an

ARLINGTON, Va., March 4, 2020 /PRNewswire/ -- Today, Governor Michelle Lujan Grisham of New Mexico signed legislation capping monthly copayments for insulin at $25, making New Mexico the third state to enact a co-pay cap—with the

BALTIMORE, March 4, 2020 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), the company behind one of the fastest-growing health and wellness communities, 

NEW YORK, March 4, 2020 /PRNewswire/ -- EmblemHealth President and CEO Karen Ignagni issued the following statement regarding the coronavirus: EmblemHealth has taken steps to ensure that all of our members have peace of mind of knowing that they will have access to the services they need. 

WASHINGTON, March 4, 2020 /PRNewswire/ -- Below is a statement from Bryan K. Barnett, President of the United States Conference of Mayors (USCM) and Mayor of Rochester Hills, MI, on the reported bipartisan agreement Congress reached today on a package to combat the coronavirus. Earlier today, USCM sent a let

NEW YORK, March 4, 2020 /PRNewswire/ -- The Mother Cabrini Health Foundation announced today it has awarded nearly $150 million

LONDON, March 4, 2020 /PRNewswire/ -- Hikma Pharmaceuticals PLC (Hikma, Group), today announces that its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals Corp.; "Hikma") is voluntarily extending its previously-announced recall of certain lots (listed below) of Ketorolac Tromethamine Inject

MISSISSAUGA, ON, March 4, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX:NRI; OTCQX:NRIFF), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Dr. Reddy's Laboratories Inc. (DRL) has launched its generic version of Vimovo in the United States

The Company announces the closure of two Canadian greenhouses, representing a significant step forward in aligning the Company's cultivation capacity with projected demand. Company expects to record estimated pre-tax charges of approximately $700-800MM in Q4 Fiscal 2020, as the Company completes its organizational & strategic review. SMITHS FALL